Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.
Human immunodeficiency virus type 1 (HIV-1) infection results in different patterns of viral replication in pediatric compared to adult populations. The role of early HIV-1-specific responses in viral control has not been well defined, because most studies of HIV-1-infected infants have been retrosp...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
_version_ | 1826302586136821760 |
---|---|
author | Lohman, B Slyker, J Richardson, B Farquhar, C Mabuka, J Crudder, C Dong, T Obimbo, E Mbori-Ngacha, D Overbaugh, J Rowland-Jones, S John-Stewart, G |
author_facet | Lohman, B Slyker, J Richardson, B Farquhar, C Mabuka, J Crudder, C Dong, T Obimbo, E Mbori-Ngacha, D Overbaugh, J Rowland-Jones, S John-Stewart, G |
author_sort | Lohman, B |
collection | OXFORD |
description | Human immunodeficiency virus type 1 (HIV-1) infection results in different patterns of viral replication in pediatric compared to adult populations. The role of early HIV-1-specific responses in viral control has not been well defined, because most studies of HIV-1-infected infants have been retrospective or cross-sectional. We evaluated the association between HIV-1-specific gamma interferon (IFN-gamma) release from the cells of infants of 1 to 3 months of age and peak viral loads and mortality in the first year of life among 61 Kenyan HIV-1-infected infants. At 1 month, responses were detected in 7/12 (58%) and 6/21 (29%) of infants infected in utero and peripartum, respectively (P = 0.09), and in approximately 50% of infants thereafter. Peaks of HIV-specific spot-forming units (SFU) increased significantly with age in all infants, from 251/10(6) peripheral blood mononuclear cells (PBMC) at 1 month of age to 501/10(6) PBMC at 12 months of age (P = 0.03), although when limited to infants who survived to 1 year, the increase in peak HIV-specific SFU was no longer significant (P = 0.18). Over the first year of life, infants with IFN-gamma responses at 1 month had peak plasma viral loads, rates of decline of viral load, and mortality risk similar to those of infants who lacked responses at 1 month. The strength and breadth of IFN-gamma responses at 1 month were not significantly associated with viral containment or mortality. These results suggest that, in contrast to HIV-1-infected adults, in whom strong cytotoxic T lymphocyte responses in primary infection are associated with reductions in viremia, HIV-1-infected neonates generate HIV-1-specific CD8+-T-cell responses early in life that are not clearly associated with improved clinical outcomes. |
first_indexed | 2024-03-07T05:49:50Z |
format | Journal article |
id | oxford-uuid:e87c75f7-9451-463f-802c-37ac8887ee5d |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T05:49:50Z |
publishDate | 2005 |
record_format | dspace |
spelling | oxford-uuid:e87c75f7-9451-463f-802c-37ac8887ee5d2022-03-27T10:47:09ZLongitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e87c75f7-9451-463f-802c-37ac8887ee5dEnglishSymplectic Elements at Oxford2005Lohman, BSlyker, JRichardson, BFarquhar, CMabuka, JCrudder, CDong, TObimbo, EMbori-Ngacha, DOverbaugh, JRowland-Jones, SJohn-Stewart, GHuman immunodeficiency virus type 1 (HIV-1) infection results in different patterns of viral replication in pediatric compared to adult populations. The role of early HIV-1-specific responses in viral control has not been well defined, because most studies of HIV-1-infected infants have been retrospective or cross-sectional. We evaluated the association between HIV-1-specific gamma interferon (IFN-gamma) release from the cells of infants of 1 to 3 months of age and peak viral loads and mortality in the first year of life among 61 Kenyan HIV-1-infected infants. At 1 month, responses were detected in 7/12 (58%) and 6/21 (29%) of infants infected in utero and peripartum, respectively (P = 0.09), and in approximately 50% of infants thereafter. Peaks of HIV-specific spot-forming units (SFU) increased significantly with age in all infants, from 251/10(6) peripheral blood mononuclear cells (PBMC) at 1 month of age to 501/10(6) PBMC at 12 months of age (P = 0.03), although when limited to infants who survived to 1 year, the increase in peak HIV-specific SFU was no longer significant (P = 0.18). Over the first year of life, infants with IFN-gamma responses at 1 month had peak plasma viral loads, rates of decline of viral load, and mortality risk similar to those of infants who lacked responses at 1 month. The strength and breadth of IFN-gamma responses at 1 month were not significantly associated with viral containment or mortality. These results suggest that, in contrast to HIV-1-infected adults, in whom strong cytotoxic T lymphocyte responses in primary infection are associated with reductions in viremia, HIV-1-infected neonates generate HIV-1-specific CD8+-T-cell responses early in life that are not clearly associated with improved clinical outcomes. |
spellingShingle | Lohman, B Slyker, J Richardson, B Farquhar, C Mabuka, J Crudder, C Dong, T Obimbo, E Mbori-Ngacha, D Overbaugh, J Rowland-Jones, S John-Stewart, G Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. |
title | Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. |
title_full | Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. |
title_fullStr | Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. |
title_full_unstemmed | Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. |
title_short | Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. |
title_sort | longitudinal assessment of human immunodeficiency virus type 1 hiv 1 specific gamma interferon responses during the first year of life in hiv 1 infected infants |
work_keys_str_mv | AT lohmanb longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT slykerj longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT richardsonb longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT farquharc longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT mabukaj longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT crudderc longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT dongt longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT obimboe longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT mboringachad longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT overbaughj longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT rowlandjoness longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants AT johnstewartg longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants |